These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3682193)

  • 1. [Bone damage of mandibles after radiotherapy of carcinoma of the tongue].
    Nakamura M; Kubo K; Furukawa S; Fuchihata H; Shimizutani K; Inoue T; Nishiyama K; Ikeda H; Masaki N
    Gan No Rinsho; 1987 Oct; 33(12):1419-26. PubMed ID: 3682193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of tolerable radiation dose on the oral mucosa and mandibular bone--external beam and/or brachytherapy].
    Horiuchi J; Takeda M; Nishio M; Mochizuki S; Morita K; Masaki N; Jingu K
    Gan No Rinsho; 1987 Aug; 33(10):1177-83. PubMed ID: 3669310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Brachytherapy--carcinoma of the tongue].
    Jingu K; Hayabuchi N; Matsui M; Wada S; Miyoshi M; Uehara S; Shimamura Y; Hirata H; Ariji E; Moriguchi S
    Gan No Rinsho; 1987 Oct; 33(13):1609-18. PubMed ID: 3694797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interstitial high-dose-rate brachytherapy in the treatment of base of tongue carcinoma.
    Takácsi-Nagy Z; Polgár C; Oberna F; Somogyi A; Major T; Remenár E; Fodor J; Kásler M; Németh G
    Strahlenther Onkol; 2004 Dec; 180(12):768-75. PubMed ID: 15592696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excellent functional outcome in patients with squamous cell carcinoma of the base of tongue treated with external irradiation and interstitial iodine 125 boost.
    Horwitz EM; Frazier AJ; Martinez AA; Keidan RD; Clarke DH; Lacerna MD; Gustafson GS; Heil E; Dmuchowski CF; Vicini FA
    Cancer; 1996 Sep; 78(5):948-57. PubMed ID: 8780531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base.
    Karakoyun-Celik O; Norris CM; Tishler R; Mahadevan A; Clark JR; Goldberg S; Devlin P; Busse PM
    Head Neck; 2005 May; 27(5):353-61. PubMed ID: 15726587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radiation ulcers after Cf-252 treatment of patients with cancer of the tongue].
    Galantseva GF; Guseva LI; Plichko VI
    Med Radiol (Mosk); 1984 Jan; 29(1):57-62. PubMed ID: 6694546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analysis of mandibular bone complications in radiotherapy for T1 and T2 carcinoma of the oral tongue.
    Fujita M; Hirokawa Y; Kashiwado K; Akagi Y; Kashimoto K; Kiriu H; Ohtani K; Wada T
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):333-9. PubMed ID: 8567334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of interstitial radiotherapy in the treatment of the base of tongue tumors: a retrospective analysis.
    Takácsi-Nagy Z; Oberna F; Polgár C; Somogyi A; Major T; Németh G
    Neoplasma; 2001; 48(1):76-81. PubMed ID: 11327543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose rate interstitial brachytherapy for mobile tongue cancer: Part 3. Comparative study of early mucosal reaction and late tongue atrophy between LDR and HDR Ir-192 interstitial brachytherapy for patients with carcinoma of the mobile tongue.
    Inoue T; Inoue T; Yoshioka Y; Yoshida K
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():296-300. PubMed ID: 10895170
    [No Abstract]   [Full Text] [Related]  

  • 11. Disease control, survival, and functional outcome after multimodal treatment for advanced-stage tongue base cancer.
    Malone JP; Stephens JA; Grecula JC; Rhoades CA; Ghaheri BA; Schuller DE
    Head Neck; 2004 Jul; 26(7):561-72. PubMed ID: 15229898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of interstitial curietherapy and combined transcutaneous radiotherapy-curietherapy in 150 patients with carcinoma of the tongue and/or mouth floor].
    Sannazzari GL; Negri GL; Ozzello F; Gabriele P; Orecchia R; Ragona R
    Radiol Med; 1986; 72(1-2):37-42. PubMed ID: 3961214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose-rate interstitial brachytherapy for oropharyngeal carcinoma: results of 83 lesions in 82 patients.
    Nose T; Koizumi M; Nishiyama K
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):983-91. PubMed ID: 15234031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late local recurrence after radiotherapy for tongue and early glottic carcinoma.
    Inoue T; Inoue T; Teshima T; Murayama S; Nose T; Tanaka E; Yamazaki H; Koizumi M; Kagawa K; Ozeki S; Ikeda H
    Strahlenther Onkol; 1996 Jun; 172(6):301-5. PubMed ID: 8677501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of brachytherapy of tongue cancer].
    Nishio M; Sakurai T; Kagami Y; Narimatsu N; Saito A; Hareyam M; Sugimori S; Asano K; Takeuchi T; Doi Y
    Gan No Rinsho; 1986 Apr; 32(4):339-44. PubMed ID: 3712772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel approach to advanced carcinoma of the tongue: cases successfully treated with combination of superselective intra-arterial chemotherapy and external/high-dose-rate interstitial radiotherapy.
    Nishioka T; Homma A; Furuta Y; Aoyama H; Suzuki F; Ohmori K; Asano T; Yoshida D; Shirato H; Fukuda S
    Jpn J Clin Oncol; 2006 Dec; 36(12):822-6. PubMed ID: 17060408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-treatment complications of soft tissue tumours.
    Shapeero LG; De Visschere PJ; Verstraete KL; Poffyn B; Forsyth R; Sys G; Uyttendaele D
    Eur J Radiol; 2009 Feb; 69(2):209-21. PubMed ID: 19101106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Retrospective study of 136 cases of epidermoid carcinoma of the base of the tongue treated at the Alexis Vautrin Centre 1978-1992].
    Hoffstetter S; Malissard L; Pernot M; Luporsi E; Peiffert D; Lapeyre M
    Bull Cancer Radiother; 1996; 83(2):90-6. PubMed ID: 8688225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brachytherapy versus surgery in carcinoma of tonsillar fossa and/or soft palate: late adverse sequelae and performance status: can we be more selective and obtain better tissue sparing?
    Levendag P; Nijdam W; Noever I; Schmitz P; van de Pol M; Sipkema D; Braat C; de Boer M; Jansen P
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):713-24. PubMed ID: 15183475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.